Insufficient scRNA-seq data for expression of CYB5R2 at single-cell level.
Insufficient scRNA-seq data for expression of CYB5R2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 99% | 1337.15 | 169 / 170 | 94% | 9.96 | 430 / 459 |
ovary | 99% | 1282.47 | 179 / 180 | 90% | 7.74 | 385 / 430 |
breast | 96% | 883.05 | 439 / 459 | 86% | 7.00 | 960 / 1118 |
prostate | 100% | 1270.76 | 244 / 245 | 79% | 3.30 | 397 / 502 |
lung | 97% | 680.88 | 559 / 578 | 77% | 8.34 | 895 / 1155 |
bladder | 86% | 736.67 | 18 / 21 | 86% | 8.53 | 432 / 504 |
skin | 100% | 2118.51 | 1809 / 1809 | 64% | 8.07 | 301 / 472 |
thymus | 80% | 319.31 | 523 / 653 | 62% | 2.09 | 373 / 605 |
esophagus | 52% | 436.91 | 745 / 1445 | 86% | 7.11 | 157 / 183 |
stomach | 48% | 185.19 | 174 / 359 | 68% | 2.83 | 194 / 286 |
brain | 70% | 670.53 | 1842 / 2642 | 46% | 2.60 | 327 / 705 |
intestine | 36% | 135.52 | 350 / 966 | 69% | 3.17 | 362 / 527 |
eye | 0% | 0 | 0 / 0 | 100% | 9.73 | 80 / 80 |
blood vessel | 97% | 661.47 | 1297 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 10.79 | 42 / 45 |
pancreas | 2% | 6.94 | 6 / 328 | 89% | 4.90 | 158 / 178 |
adipose | 89% | 498.40 | 1070 / 1204 | 0% | 0 | 0 / 0 |
kidney | 69% | 278.26 | 61 / 89 | 20% | 0.71 | 182 / 901 |
lymph node | 0% | 0 | 0 / 0 | 86% | 13.83 | 25 / 29 |
adrenal gland | 24% | 88.53 | 62 / 258 | 35% | 1.66 | 80 / 230 |
liver | 16% | 54.62 | 37 / 226 | 20% | 0.69 | 80 / 406 |
spleen | 20% | 66.32 | 47 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 223.28 | 179 / 929 | 0% | 0 | 0 / 0 |
heart | 18% | 68.21 | 159 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 17.79 | 40 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016126 | Biological process | sterol biosynthetic process |
GO_0015701 | Biological process | bicarbonate transport |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0071949 | Molecular function | FAD binding |
GO_0004128 | Molecular function | cytochrome-b5 reductase activity, acting on NAD(P)H |
GO_0005515 | Molecular function | protein binding |
Gene name | CYB5R2 |
Protein name | NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2) cytochrome-b5 reductase (EC 1.6.2.2) |
Synonyms | |
Description | FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction (By similarity). Responsible for NADH-dependent lucigenin chemiluminescence in spermatozoa by reducing both lucigenin and 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-[2,4-disulfophenyl]-2H tetrazolium monosodium salt (WST-1). . |
Accessions | Q6BCY4 ENST00000533558.5 [Q6BCY4-1] ENST00000531096.5 ENST00000524790.5 [Q6BCY4-2] E9PMI2 E9PQW2 E9PIV9 E9PRM4 ENST00000436351.2 ENST00000299498.11 [Q6BCY4-1] ENST00000524608.5 ENST00000527542.5 |